Last reviewed · How we verify

NCT04641715

OAGB-MGB Conversions for Post-operative Complications

Completed Last updated 1 December 2020
What this trial tests

trial testing OAGB-MGB in Bariatric Surgery Candidate in 207 participants. Completed in 17 November 2020.

Timeline
1 November 2020
Primary endpoint
17 November 2020
17 November 2020

Quick facts

Lead sponsorFederico II University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment207
Start date1 November 2020
Primary completion17 November 2020
Estimated completion17 November 2020
Sites1 location across Italy

Drugs / interventions tested

Conditions studied

Sponsor

Federico II University

Who can join

Eligibility, any sex, with Bariatric Surgery Candidate. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Laparoscopic mini/one anastomosis gastric bypass (MGB/OAGB) is a relatively new bariatric procedure and is gaining ground over the surgical approach for morbid obesity as a safe and effective operation. Revision of MGB/OAGB was never studied before as multicenter data collection: we collected data from 21 italian centers who perform MGB/OAGB to evaluate patients' conditions which determinated the conversion from this procedure to another kind of bariatric technique.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Revisional Surgery After One Anastomosis/Minigastric Bypass: an Italian Multi-institutional Survey.
    Musella M, Vitiello A, Susa A, Greco F, et al · · 2022 · cited 26× · PMID 34973123 · DOI 10.1007/s11695-021-05779-y

Verify or expand the search:

Other recruiting trials for Bariatric Surgery Candidate

Currently open trials in the same condition.

Other Federico II University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04641715.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing